Researchers have announced several major advances in physiology, including a blood-based molecular model linking biomarkers ...
A predictive model for psoriasis relapse risk demonstrates moderate performance, according to a study published online April ...
B, an open-source AI foundation model that predicts Alzheimer's risk with 4x higher accuracy using multi-omic data.
Patterns of molecular activity in the blood may hold clues not only to how fit someone is, but also to the biological ...
SAS AI Navigator offers a unified view of whatever models and tools a team is already using, including LLMs, AI agents and ...
Patients who develop myocarditis within the first month of receiving immune checkpoint inhibitor therapy are more likely to have MC fatality.
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the availability of an AI ...
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced ...
Opinion: As AI use becomes more frequent in the invention of new drugs, it’s important to determine how it affects who’s ...
The Pentagon has signed a classified AI agreement with Google and is expanding live drone-on-drone combat training for the 82nd Airborne Division, reflecting a rapid acceleration of AI integration ...
Whether estimating the probability that a disease is present or forecasting risk of deterioration,1 readmission,2 or death,3 most contemporary clinical artificial intelligence (AI) systems are ...
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced continued progress within its artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results